Receipt of Recommended Therapy by Patients with Advanced Colorectal Cancer

Abstract

Most colon cancer patients at a major VA medical center receive recommended therapy. Among rectal cancer patients, those presented at tumor board are most likely to receive recommended therapy.

Establishment of a Regional Virtual Tumor Board Program to Improve the Process of Care for Patients With Hepatocellular Carcinoma

“…It is well established that MDE through a TB forum significantly improves staging accuracy 25 and ensures that correct management decisions and guideline-driven recommendations are made for patients with cancer. 25,26 Our study focused on measures examining the quality of the process of care, and although the relatively small sample size limited our ability to examine the effect on treatment for each corresponding stage or liver function category, we feel that improving the quality of the MDE process provides the ideal framework to consider all relevant factors when determining the best treatment approach for each individual patient.…”

Lung cancer in elderly patients

“…They are crucial to generate coordinated treatment plans and improve timely access to care (52); they allow better adherence to guidelines and help overcome the potential bias of the treating or diagnosing physician (53,54). These boards work not only as mechanisms for improving patient care but also as educational forums; particularly, they provide significant educational exposure for postgraduate trainees at University Institutions (55,56).…”

Physicians’ Beliefs About the Benefits and Risks of Adjuvant Therapies for Stage II and Stage III Colorectal Cancer

“…When chemoradiotherapy is delivered preoperatively, postoperative adjuvant chemotherapy is not always administered. 2,6 We found, somewhat paradoxically, that medical oncologists were more likely than radiation oncologists and surgeons to endorse the net benefits of adjuvant chemotherapy and radiotherapy for stage II rectal cancers, but less likely to endorse adjuvant chemotherapy for stage II colon cancer. Because radiation oncologists and general surgeons are less often involved in treating colon cancer patients, they may be less familiar with the limited indications for chemotherapy in stage II disease.…”

“…[1][2][3][4][5][6] Patients with colorectal cancer who receive guideline-concordant therapy survive longer than those who do not, 3,7,8 yet many patients do not receive recommended therapies. Physicians are less likely to offer adjuvant therapy to older patients with colorectal cancer with medical comorbidities than to younger and healthier patients.…”